Lung Transplantation Unit, University Hospital Gasthuisberg, Leuven, Belgium. geert.verleden @ uzleuven.be
Respiration. 2011;81(6):441-5. doi: 10.1159/000326934. Epub 2011 May 16.
Lung transplantation offers a major survival benefit in selected patients with end-stage pulmonary disease. In recent years, there is accumulating evidence of an increase in solid organ tumors and especially in primary lung cancer. There is also some anecdotal evidence that lung transplantation may be beneficial as a treatment option in some patients with lung cancer, such as the ones with extensive bronchoalveolar cell carcinoma. In this review, we analyze the literature data reporting the incidence of lung cancer after lung transplantation with its inherent risk factors, and we summarize the available data on possible treatment of lung cancer by lung transplantation. Finally, bronchial epithelial chimerism as possible cause for lung cancer is discussed.
肺移植为特定终末期肺部疾病患者带来显著生存获益。近年来,实体器官肿瘤尤其是原发性肺癌发病率不断增加。此外,也有一些传闻证据表明,肺移植可能对某些肺癌患者有益,如广泛细支气管肺泡细胞癌患者。本综述分析了报道肺移植后肺癌发病率及其固有危险因素的文献数据,并总结了肺移植治疗肺癌的现有数据。最后讨论了支气管上皮嵌合体作为肺癌可能病因的问题。